A phase I trial combining decitabine/dendritic cell vaccine targeting MAGE-A1, MAGE-A3 and NY-ESO-1 for children with relapsed or therapy-refractory neuroblastoma and sarcoma

2015 ◽  
Vol 64 (10) ◽  
pp. 1251-1260 ◽  
Author(s):  
Deepa K. Krishnadas ◽  
Suzanne Shusterman ◽  
Fanqi Bai ◽  
Lisa Diller ◽  
Janice E. Sullivan ◽  
...  
2012 ◽  
Vol 62 (1) ◽  
pp. 125-135 ◽  
Author(s):  
Surasak Phuphanich ◽  
Christopher J. Wheeler ◽  
Jeremy D. Rudnick ◽  
Mia Mazer ◽  
HongQian Wang ◽  
...  

Cytotherapy ◽  
2017 ◽  
Vol 19 (5) ◽  
pp. S15 ◽  
Author(s):  
A.A. Tryggestad ◽  
I. Bigalke ◽  
K. Axcrona ◽  
E. Inderberg ◽  
G. Skorstad ◽  
...  

2008 ◽  
Vol 15 (2) ◽  
pp. 114-121 ◽  
Author(s):  
David G. Walker ◽  
Richard Laherty ◽  
Frank H. Tomlinson ◽  
Teong Chuah ◽  
Chris Schmidt

2012 ◽  
Vol 72 (4 Supplement) ◽  
pp. A16-A16 ◽  
Author(s):  
Pierre Major ◽  
Louis Lacombe ◽  
Yves Fradet ◽  
Ronan Foley ◽  
Elizabeth Scheid ◽  
...  

Gene Therapy ◽  
2011 ◽  
Vol 18 (6) ◽  
pp. 584-593 ◽  
Author(s):  
J C Steele ◽  
A Rao ◽  
J R Marsden ◽  
C J Armstrong ◽  
S Berhane ◽  
...  

2005 ◽  
Vol 28 (6) ◽  
pp. 615
Author(s):  
Sun min Lee ◽  
Marta Schilling ◽  
Tramy Vo ◽  
Fred Aono ◽  
Amy Nguyen ◽  
...  

Sign in / Sign up

Export Citation Format

Share Document